Metagenomi, Inc. Common Stock beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.63 | $-0.73 | -15.9% | Miss |
| Q12026 FY2026 | $-0.60 | $-0.61 | -1.7% | Miss |
| Q42025 FY2025 | $-0.58 | $-0.60 | -3.5% | Miss |
Back to MGX overview · MGX holders · MGX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.